Bristol-Myers Squibb Balance Sheet Health
Financial Health criteria checks 3/6
Bristol-Myers Squibb has a total shareholder equity of $16.5B and total debt of $55.7B, which brings its debt-to-equity ratio to 336.5%. Its total assets and total liabilities are $99.0B and $82.5B respectively. Bristol-Myers Squibb's EBIT is $8.3B making its interest coverage ratio 10.8. It has cash and short-term investments of $9.7B.
Key information
336.5%
Debt to equity ratio
US$55.68b
Debt
Interest coverage ratio | 10.8x |
Cash | US$9.67b |
Equity | US$16.55b |
Total liabilities | US$82.48b |
Total assets | US$99.03b |
Recent financial health updates
Recent updates
Bristol-Myers Squibb: A Lost Decade?
May 03Lacklustre Performance Is Driving Bristol-Myers Squibb Company's (NYSE:BMY) Low P/S
Apr 29Is Bristol Myers Squibb A Buy At These Bottom Levels?
Apr 22Bristol Myers Squibb: Seriously Undervalued At Peak Pessimism (Rating Upgrade)
Apr 12Bristol-Myers Squibb Is A Speculative Buy On Price Action (Technical Analysis)
Apr 02Bristol-Myers Squibb (NYSE:BMY) Is Due To Pay A Dividend Of $0.60
Mar 21Bristol-Myers Squibb Is Not A Buy For Me
Mar 19Bristol-Myers Squibb: Compelling Value From The New Products Portfolio And 4.5% Yield
Mar 07Bristol-Myers Squibb (NYSE:BMY) Is Due To Pay A Dividend Of $0.60
Mar 07We Think Bristol-Myers Squibb's (NYSE:BMY) Healthy Earnings Might Be Conservative
Feb 20Bristol-Myers Squibb Company (NYSE:BMY) Just Released Its Annual Results And Analysts Are Updating Their Estimates
Feb 06Bristol-Myers Squibb: Massive Discount Spells Opportunity
Feb 04BMY: Might Be Approaching A Bottom In 2024
Jan 23Investors Aren't Entirely Convinced By Bristol-Myers Squibb Company's (NYSE:BMY) Earnings
Jan 16Bristol-Myers Squibb: I Went Looking For Value And Found A 4.63% Yield Also
Jan 10Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation
Dec 31Bristol-Myers Squibb (NYSE:BMY) Has Announced That It Will Be Increasing Its Dividend To $0.60
Dec 26Bristol Myers Squibb: This Dividend Contender Is A Steal Right Now
Dec 19Bristol-Myers Squibb: A Nice Deal For This Bargain Pharma Stock
Dec 12Bristol-Myers Squibb (NYSE:BMY) Is Increasing Its Dividend To $0.60
Dec 11Bristol-Myers Squibb: The Patent Expiry Challenge
Nov 23Bristol Myers Squibb: Bright Future Ahead
Nov 17Bristol-Myers Squibb (NYSE:BMY) Has A Pretty Healthy Balance Sheet
Nov 08Financial Position Analysis
Short Term Liabilities: BMY's short term assets ($28.7B) exceed its short term liabilities ($25.8B).
Long Term Liabilities: BMY's short term assets ($28.7B) do not cover its long term liabilities ($56.7B).
Debt to Equity History and Analysis
Debt Level: BMY's net debt to equity ratio (278%) is considered high.
Reducing Debt: BMY's debt to equity ratio has increased from 39.3% to 336.5% over the past 5 years.
Debt Coverage: BMY's debt is well covered by operating cash flow (24.6%).
Interest Coverage: BMY's interest payments on its debt are well covered by EBIT (10.8x coverage).